Investor coalitions are setting priorities for policy-level engagement amid mounting evidence of threats to resilience from systemic risks.
Donald Trump’s decision to repeal existing measures unlikely to dissuade investors from engaging with pharmaceutical companies.
Investors can play a part in turning the tide against PFAS, says Sudip Hazra, Director of the First Sentier MUFG Sustainable Investment...
Maria Larsson Ortino, Senior Global ESG Manager at Legal and General Investment Management, outlines the role of asset owners and managers in...
Tackling the UK’s health challenges requires a whole-of-society response, including from investors, explains Anna Taylor, Executive Director at The Food Foundation.
Statement urges global leaders to create a unifying set of “evidence-based steps” to tackle antimicrobial resistance.
CCLA highlights high and persistent systemic risks of forced labour across the sector in an engagement initiative.
A selection of the major stories impacting ESG investors, in five easy pieces.
The case for allocating to social investment solutions has never been clearer and relevant, according to Big Issue Invest Chair Mark Porter.
Matt Lawton, Portfolio Manager of T Rowe Price’s Global Impact Credit strategy, identifies three sectors which offer impact and returns to bond...
Subscribe to our free weekly newsletter below and never miss a story.